In this Friday’s PCT Grand Rounds, Dr. Konstantin Dragnev and Dr. Karen Reckamp will present “S2302 Pragmatica-Lung: New Directions for Decreasing Burden and Increasing Inclusion in NCTN Clinical Trials.”
The Grand Rounds session will be held on Friday, February 24, 2023, at 1:00 pm eastern.
S2302 Pragmatica-Lung is pragmatic clinical trial testing the effect of ramucirumab and pembrolizumab vs standard treatment on overall survival among patients whose non-small-cell lung cancer has advanced after immunotherapy and chemotherapy. The trial is being conducted in the National Cancer Institute’s National Clinical Trials Network of more than 2000 academic and community clinical sites.
Dragnev is a professor of medicine and the Irene Heinz Given Professor in Pharmacology in the Dartmouth Geisel School of Medicine and associate director for clinical research at the Dartmouth Cancer Center. Reckamp is a professor in medicine, director of the Division of Medical Oncology, and associate director of clinical research at Cedars-Sinai Cancer Center.